Cargando…

A novel immunocompetent murine model for replicating oncolytic adenoviral therapy

Oncolytic adenoviruses are under investigation as a promising novel strategy for cancer immunotherapeutics. Unfortunately, there is no immunocompetent mouse cancer model to test oncolytic adenovirus because murine cancer cells are generally unable to produce infectious viral progeny from human adeno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, L, Hedjran, F, Larson, C, Perez, G L, Reid, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298785/ https://www.ncbi.nlm.nih.gov/pubmed/25525035 http://dx.doi.org/10.1038/cgt.2014.64

Ejemplares similares

Impact of Autophagy in Oncolytic Adenoviral Therapy for Cancer
por: Tazawa, Hiroshi, et al.
Publicado: (2017)

A Local and Abscopal Effect Observed with Liposomal Encapsulation of Intratumorally Injected Oncolytic Adenoviral Therapy
por: Dong, Tao, et al.
Publicado: (2023)

Development of a Syrian hamster anti-PD-L1 monoclonal antibody enables oncolytic adenoviral immunotherapy modelling in an immunocompetent virus replication permissive setting
por: Clubb, James H. A., et al.
Publicado: (2023)

A Comparative Study of Replication-Incompetent and -Competent Adenoviral Therapy-Mediated Immune Response in a Murine Glioma Model
por: Kim, Julius W., et al.
Publicado: (2017)

Carvedilol targets β-arrestins to rewire innate immunity and improve oncolytic adenoviral therapy
por: Hoare, Joseph I., et al.
Publicado: (2022)

Going viral: a review of replication-selective oncolytic adenoviruses
por: Larson, Christopher, et al.
Publicado: (2015)

Combinatorial treatment with oncolytic adenovirus and helper-dependent adenovirus augments adenoviral cancer gene therapy
por: Farzad, Lisa, et al.
Publicado: (2014)

Disseminated adenoviral disease in immunocompetent adults supported with extracorporeal membrane oxygenation
por: Murughan, Kavita, et al.
Publicado: (2020)

Interleukin 8 activity influences the efficacy of adenoviral oncolytic immunotherapy in cancer patients
por: Taipale, Kristian, et al.
Publicado: (2018)

Systemic delivery and SPECT/CT in vivo imaging of (125)I-labelled oncolytic adenoviral mutants in models of pancreatic cancer
por: Stella Man, Y. K., et al.
Publicado: (2019)

p21 promotes oncolytic adenoviral activity in ovarian cancer and is a potential biomarker
por: Flak, Magdalena B, et al.
Publicado: (2010)

Extracellular vesicles provide a capsid-free vector for oncolytic adenoviral DNA delivery
por: Saari, Heikki, et al.
Publicado: (2020)

Delta-24-RGD Oncolytic Adenovirus Elicits Anti-Glioma Immunity in an Immunocompetent Mouse Model
por: Jiang, Hong, et al.
Publicado: (2014)

Editorial: Adenoviral Infection and Immunity, and Adenoviral Vectors for Gene Therapy Applications
por: Zhang, Qiwei, et al.
Publicado: (2022)

Combination Therapy of Novel Oncolytic Adenovirus with Anti-PD1 Resulted in Enhanced Anti-Cancer Effect in Syngeneic Immunocompetent Melanoma Mouse Model
por: Garofalo, Mariangela, et al.
Publicado: (2021)

Immunocompetent murine models for the study of glioblastoma immunotherapy
por: Oh, Taemin, et al.
Publicado: (2014)

Oncograms Visualize Factors Influencing Long-Term Survival of Cancer Patients Treated with Adenoviral Oncolytic Immunotherapy
por: Hemminki, Otto, et al.
Publicado: (2018)

Enhanced oncolytic adenoviral production by downregulation of death-domain associated protein and overexpression of precursor terminal protein
por: Lee, Jihyun, et al.
Publicado: (2021)

Mesenchymal stem cell carriers enhance antitumor efficacy of oncolytic adenoviruses in an immunocompetent mouse model
por: Rincón, Esther, et al.
Publicado: (2017)

Intra-arterial adenoviral mediated tumor transfection in a novel model of cancer gene therapy
por: Cabrera, Gustavo, et al.
Publicado: (2006)

Second-generation HIF-activated oncolytic adenoviruses with improved replication, oncolytic, and anti-tumor efficacy
por: Cherry, Tiffani, et al.
Publicado: (2010)

Nucleocapsid as a next-generation COVID-19 vaccine candidate
por: Oronsky, Bryan, et al.
Publicado: (2022)

A new oncolytic adenoviral vector carrying dual tumour suppressor genes shows potent anti-tumour effect
por: Liu, Xin-Ran, et al.
Publicado: (2012)

Comparison of Replication-Competent, First Generation, and Helper-Dependent Adenoviral Vaccines
por: Weaver, Eric A., et al.
Publicado: (2009)

Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines
por: Coughlan, Lynda
Publicado: (2020)

Oncolytic Replication of E1b-Deleted Adenoviruses
por: Cheng, Pei-Hsin, et al.
Publicado: (2015)

Oncolytic adenovirus targeting cyclin E overexpression repressed tumor growth in syngeneic immunocompetent mice
por: Cheng, Pei-Hsin, et al.
Publicado: (2015)

Adenoviral Vectors for Hemophilia Gene Therapy
por: Brunetti-Pierri, N, et al.
Publicado: (2013)

Immunology of Adenoviral Vectors in Cancer Therapy
por: Shaw, Amanda Rosewell, et al.
Publicado: (2019)

In vivo bioimaging tracks conditionally replicative adenoviral replication and provides an early indication of viral antitumor efficacy
por: Davydova, Julia, et al.
Publicado: (2010)

Expanding the Spectrum of Adenoviral Vectors for Cancer Therapy
por: Gao, Jian, et al.
Publicado: (2020)

First detection of dengue virus in the saliva of immunocompetent murine model
por: Rasinhas, Arthur da Costa, et al.
Publicado: (2018)

Oncolytic influenza virus infection restores immunocompetence of lung tumor-associated alveolar macrophages
por: Masemann, Dörthe, et al.
Publicado: (2018)

Oncolytic activity of naturally attenuated herpes-simplex virus HF10 against an immunocompetent model of oral carcinoma
por: Takano, Gaku, et al.
Publicado: (2020)

Oncolytic Adenoviral Vector-Mediated Expression of an Anti-PD-L1-scFv Improves Anti-Tumoral Efficacy in a Melanoma Mouse Model
por: Vitale, Maria, et al.
Publicado: (2022)

P1250: EU-SOX11CCND1: A NOVEL IMMUNOCOMPETENT MURINE MODEL OF MANTLE CELL LYMPHOMA
por: Brown, F., et al.
Publicado: (2022)

Therapeutic Applications for Oncolytic Self-Replicating RNA Viruses
por: Lundstrom, Kenneth
Publicado: (2022)

Evaluation of tumor immunity after administration of conditionally replicative adenoviral vector in canine osteosarcoma patients
por: Agarwal, Payal, et al.
Publicado: (2021)

TGF-β Inhibition Improves Oncolytic Herpes Viroimmunotherapy in Murine Models of Rhabdomyosarcoma
por: Hutzen, Brian, et al.
Publicado: (2017)

Cooperation of Oncolytic Herpes Virotherapy and PD-1 Blockade in Murine Rhabdomyosarcoma Models
por: Chen, Chun-Yu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kkvl2d8osjjpeo0gknb23uiil5